trial · primary record
DNAJB1-PRKACA Peptide Vaccine
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 27 |
| Primary completion | 2030-10 |
| Primary endpoint | Number of participants experiencing grade 3 or above drug-related toxicities |
| Registry ID | NCT07430202 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:44.179Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07430202
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.